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Abstract Background Bowel flaps are a good and reliable method to restore the continuity of
the aerodigestive tract. Radiated fields, contaminated recipient sites, or depleted
recipient vessels may increase the risk for ischemic injury after transfer. During
ischemic events, we believe that bowel conduits with serosa have a delayed neovascu-
larization process at its new recipient site.
We conducted an ischemia/reperfusion murine model to understand the difference
among bowel conduits with and without serosa.
Materials and Methods Two groups of rats were compared: control group (jejunal
conduit with serosa) and a target group (jejunal conduit without serosa). These
conduits were harvested from the peritoneal cavity and transferred into a subcuta-
neous pocket. After 72 hours of transfer and pedicle ligation, histological changes
related to ischemia/reperfusion were assessed. In addition, tissue markers of angio-
genesis (CD34), ischemia (lactate dehydrogenase [LDH]), and inflammation (inter-
leukin [IL]-1β and IL-6) were analyzed.
Results Two groups (n ¼ 20) of male rats were analyzed. Histology showed intact
jejunal mucosa in the target group. The control group showed decreased number of
mucin, globet cells, decreased height, and fragmentation of villi with the absence of
intestinal glands. Markers of angiogenesis (CD34) were higher in the target group. In
addition, markers of ischemia (LDH) (p ¼ 0.0045) and inflammation (IL-1b,
p ¼ 0.0008, and IL-6, p ¼ 0.0008) were significantly lower in the target group as
compared with the control group.
Conclusions In circumstances in which the recipient site does not offer an adequate
and healthy bed or a vascular insult occurs, bowel flaps with less amount of serosa may
be able to neovascularize faster thereby increasing its chances of survival.
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Reconstruction of the pharyngoesophageal tract with bowel
flaps has been described as a good and reliable method to
restore the continuity of the aerodigestive tract.1–5However,
when clinical factors such as a radiated field, contaminated
recipient site or depleted recipient vessels are encountered,
an alternative surgical approach is necessary. With any
ischemic insult, bowel mucosa becomes very sensitive to
prolonged absence of vascular supply or congestion, leading
to epithelial damage, bacteria translocation, and possible
failure of the conduit.6 In an effort to findways to limit bowel
ischemia following transfer, animal models using prefabri-
cated bowel flaps have been described.7 Several of these
studies have evaluated ways to promote early and faster
neovascularization of the transferred bowel segment to
prevent stricture, limit epithelial damage, and prevent per-
foration. One of the main anatomical differences between
some common flaps used to reconstruct the aerodigestive
track, such as the jejunum or the ileocolon flaps, is the lack of
serosa in the posterior wall of the ileum and colon.8,9
Based on our clinical experience, we hypothesize that the
serosa may delay the neovascularization process after the
bowel conduit has been transferred to its recipient site.
Using a validated murine model,7 the purpose of this
study was to examine the physiological response of bowel
conduits with and without serosa to analyze the neovascu-
larization and integration process of these conduits after
transfer under simulated ischemia.
Material and Methods
Animal Model
Male Sprague Dawley rats (BioLASCO, Taiwan Co.) weighing
between 350 and 500 g were used under the animal care and
laboratory standards in accordance with the guidelines of
China Medical University Hospital. Two groups were com-
pared: group A (control), jejunal conduit with intact serosa,
and group B, jejunal conduit with no serosa. The animals
were anesthetized with an intramuscular injection of Zoletil
(tiletamine 40 mg/kg; Virbac, Australia). In addition, pre-
operative antibiotics (gentamicin 4 mg/0.2 mL) were admi-
nistrated intramuscularly before surgery. The abdominal
skin was shaved and prepared with povidone–iodine.
Through midline laparotomy (►Fig. 1), a 4-cm segment of
jejunum was visualized and divided keeping the vascular
pedicle straight to prevent twisting. The chosen segmentwas
based on a uniform blood vessel distribution to the bowel
conduit. In addition, we preserved the anatomical peristaltic
direction of the bowel conduit prior to its transfer into an
abdominal subcutaneous pocket to prevent twisting of the
bowel (►Figs. 2 and 3). After the segment of bowel was
divided and under microscope magnification (40  , Leica
Microsystems, model M651, Schweiz AG), the serosa was
removed sharply using curved microsurgical scissors. The
average time used to remove the serosa from each bowel
segment was 40 minutes (range: 35–45 minutes). After the
bowel segment was harvested, the proximal and distal ends
of the rest of the bowel were anastomosed using 6–0 nylon,
thus restoring the continuity of the gastrointestinal tract.
While still attached to its pedicle, the segment of jejunum
was mobilized and brought out of the abdominal cavity and
placed under a subcutaneous skin pocket. A 6–0 nylon loop
was placed at the base of the vascular pedicle to ligate it
72 hours after transfer without disrupting the possible new
areas of neovascularization between the conduit and sur-
rounding tissues. The midline laparotomy was closed with
interrupted 4–0 nylon, leaving a small hiatus to allow free
passage of the jejunal vascular pedicle (►Fig. 3). The bowel
conduit was irrigated and a distal jejunostomy was made on
the left side of the abdominal skin to prevent accumulation of
secretions in the postoperative period and to monitor the
perfusion of the bowel conduit. After the vascular pedicle
was ligated, the jejunal conduit was maintained under the
skin flap for additional 72 hours. At that point, the jejunal
conduit was harvested for further tissue and blood analysis.
For group B, the same procedures were performed, but in
addition, prior to placing the jejunal conduit in the subcu-
taneous pocket, careful serosal stripping was performed
under the microscope as previously described. Viability of
the bowel was assessed by gross appearance (color and
peristalsis), and histological examination was performed
72 hours after pedicle ligation. Histological sections were
prepared with hematoxylin and eosin stains and viewed
under 100 and 200 magnification looking for ischemic
changes in the bowel epithelium. In addition, markers of
bowel angiogenesis, such as CD34, bowel ischemia, such as
lactate dehydrogenase (LDH), and bowel inflammation, such
as IL-1β and IL-6, were recorded. To compare the difference
Fig. 1 Under anesthesia, the animal’s jejunum is accessed through a
midline laparotomy incision.
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amongour groups, aWilcoxon rank sum-test was performed.
Statistical analysis was conducted using SAS 9.4 software
(SAS Institute, Cary, NC). All statistical tests were two-sided
with a significance level of 0.05.
Results
After 72 hours of ligation, 20 jejunal conduits were harvested
(n ¼ 10 serosa; n ¼ 10 no serosa). Histological sections
using hematoxylin and eosin stains of the jejunum were
compared under 100 and 200magnification. Our control
group (bowel with serosa) showed decrease number of
mucin, globet cells, decrease height, and fragmentation of
villous with the absence of intestinal glands. However, in our
stripped serosal model, they showed intact jejunal mucosa
with tall intestinal villi, deep intestinal glands (crypts of
Lieberkuhn), and numerous plump globet cells (►Fig. 4).
To correlate our previous findings and to look for other
signs of angiogenesis, CD34 stains were also performed.
Histological sections at 200 magnification showing
CD34 immunohistochemistry stain of bowel mucosa
72 hours after pedicle ligation were analyzed. A scattered
number of CD34 with fibrosis and decreased amount of
capillaries at the endothelium level were observed in our
control group. However, an increased number of CD34
stains over bowel mucosa (black arrows) with increased
number of capillaries were seen in the rats with serosal
stripping (►Fig. 5).
Looking for biomarkers of ischemia, LDH was obtained in
blood samples of both groups 72 hours after ligation. Com-
paring LDH levels among our control and experimental
group, higher levels of LDH were seen in our control group
(median 952.5 vs. 625.5 IU/L; p ¼ 0.0045; ►Fig. 6).
In addition, biomarkers of inflammation such as IL-1β and
IL-6 were compared among groups. After 72 hours of liga-
tion, tissue samples were obtained. IL-1β and IL-6 were
significantly higher in the control group as compared with
the no-serosa model (median 679.5 vs. 276.5 pg/mL,
p ¼ 0.0008 for IL-1β [►Fig. 7]; median 67.5 pg/L vs.
15.0 pg/L, p ¼ 0.0008 for IL-6 [►Fig. 8]).
Discussion
In 1992, Kawahara et al described thefirst experience of bowel
conduits for pharyngolaryngectomy reconstruction.10 In ad-
dition, several other studies have shown the efficacy, relia-
bility, and promising results used in aerodigestive tract
reconstruction with minimal donor-site morbidity.5,6,11–15
However, due to the low threshold for ischemia, interruption
in its vascular supply will result in hypoxia and injury to the
intestinal epithelium. At the same time, the inflammation
generated by this vascular event will increase the oxygen
Fig. 2 (A) Exploration of jejunum with complete mesenteric arcade prior to division. (B) Division of proximal and distal jejunum ends with intact
mesenteric vascular supply.
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consumption of the affected cells.16 This is due to their large
surface area in conjunctionwith their complexvascular supply
system.17 In addition, the anaerobic environment of the bowel
lumen will lead to an extremely steep oxygen gradient across
the bowel epithelium, leading to bacterial translocation and
possible sepsis.16
Based on our clinical experience, pharyngolaryngectomy
reconstruction in patients who lack recipient site vessels,
history of recipient site radiation, or heavy contamination
can become very challenging.6 When these issues are antici-
pated, selection of an appropriate bowel flap is important.
Conduits with a quicker process of neovascularization and
that integrates faster into its recipient site are preferred. One
of the most common type of bowel flaps used during
pharyngolaryngectomy reconstruction are the jejunum and
the ileocolon flaps.5 In the last decade, our group has con-
ducted a significant number of aerodigestive track recon-
structions using free and pedicle bowel flaps.8,12,13,18–20
Even though the success rate of these flaps is high,6 we
have noticed that when a ischemic event occurs, the portion
of the bowel conduit that survives is usually the one not
covered by serosa (e.g., posterior wall of the terminal ileum
and ascending colon). However, and up to now, no study has
demonstrated this physiological process among bowel con-
duits with and without serosa during ischemic events.
To analyze and understand the different mechanisms
involved in bowel ischemia/reperfusion injury, inflamma-
tion, and angiogenesis, we decided to compare among our
groups different biological markers involved in this process.
In bowel ischemia, LDH is an important marker that
correlates with the index of cell injury and bowel ische-
mia/reperfusion.21–24 The reduction of oxygen supply im-
pairs the mitochondria respiration process and triggers a
cytoplasmic low-performance, energy-producing process.
This will eventually turn from an aerobic to an anaerobic
metabolism, having lactate as the end product of this path-
way. The low LDH levels (p ¼ 0.0045) seen in our stripping
serosamodelmost likely represent a reduced ischemic insult
due to a faster integration process and angiogenesis at the
recipient site (►Fig. 6).
The low LDH levels also correlate with the histopatholo-
gical findings seen in the same group, a more intact histo-
logical architecture as seen on hematoxylin and eosin
examination 72 hours after pedicle ligation (►Fig. 4). The
intact jejunal mucosawith tall intestinal villi, deep intestinal
Fig. 4 Histological section (hematoxylin and eosin stain) at 100magnification showing bowel mucosa 72 hours after pedicle ligation. (A) The
control group shows decreased number of mucin, globet cells, decreased height, and fragmentation of villous with the absence of intestinal
glands. (B) Intact jejunal mucosa with tall intestinal villi, deep intestinal glands (crypts of Lieberkuhn), and numerous plump globet cells.
Fig. 3 Closure of midline laparotomy leaving a small hiatus for
passage of the mesenteric pedicle supplying the segment of the
jejunum. A loop of 6–0 nylon is left at the base of the pedicle for
ligation 72 hours after placement in the subcutaneous pocket.
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glands (crypts of Lieberkuhn), and numerous plump globet
cells confirms a possible decreased ischemic event with a
faster angiogenesis phase.
Since the late 1990s, CD-34 has been described as a strong
marker for endothelial cell proliferation, vascular regenera-
tion, angiogenesis, and tissue healing.25–27 In ischemic
events, progenitor cells mobilize and adhere to sites of
vascular lesions inducing endothelial proliferation. In our
jejunal conduit model, the group lacking of serosa demon-
strated an increase in the number of CD-34 cells, as seen
in ►Fig. 5. The increased number of vessels represents a
stronger neovascularization and angiogenesis process of the
deserosalized conduit at the recipient site. This physiological
response might allow the transferred conduit to integrate
faster and survive in the event of occlusion of itsmain pedicle
based on its new blood supply, as demonstrated in our
murine model.
Fig. 6 Lactate dehydrogenase in blood samples for the serosa and the
no-serosa groups (median 952.5 IU/L for the serosa group vs.
625.5 IU/L for the no-serosa group; p ¼ 0.0045). The three horizontal
lines are the third quartile, median, and the first quartile, respectively,
from top to bottom.
Fig. 7 Interleukin-1β compared between the groups of serosa and
no-serosa (median 679.5 vs. 276.5 pg/mL; p ¼ 0.0008). The three
horizontal lines are the third quartile, median, and the first quartile,
respectively, from top to bottom.
Fig. 8 Interleukin-6 compared between the groups of serosa versus
no-serosa (median 67.5 vs. 15.0 pg/L; p ¼ 0.0008). The three
horizontal lines are the third quartile, median, and the first quartile,
respectively, from top to bottom.
Fig. 5 Histological section at 200 magnification showing CD34 immunohistochemistry stain of bowel mucosa 72 hours after pedicle ligation.
(A) Scattered number of CD34 with fibrosis and decreased amount of capillaries at the endothelium level in the control group (rats with complete serosa).
(B) Increased number of CD34 stains over bowel mucosa (black arrows) with increased number of capillaries in rats with serosal stripping.
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During an ischemic injury insult, several other proinflam-
matory cytokines such as IL-1β and IL-6 have been shown to
be important markers of tissue injury.28 The role of these
interleukins is to lead to the influx and activation of neu-
trophils, resulting in inflammation of the injured tissue. Both
of these cytokines are potent pleiotropic, proinflammatory
mediators responsible for the acute-phase response during
ischemic events.
The low levels of both cytokines (IL-1β and IL-6) encoun-
tered in our deserosalized animal model also shows a lesser
degree of inflammation and ischemic injury. This might
represent a faster adaptation and angiogenesis process of
the conduit into its new recipient site (►Figs. 7 and 8).
The serosa represents the most external layer of the
bowel. This layer consists of connective tissue covered by a
simple squamous epithelium,which reduces frictional forces
during digestive movements by secreting serous fluid. The
serosal layer forms a natural barrier from the spread of
inflammatory and other malignant processes.
Free tissue transfer based on bowel conduits for pharyn-
golaryngectomy reconstruction has been used for many
years with very promising outcomes.10,14,15,19 From the
clinical standpoint and based on many years of clinical
observation by the senior author,3,5,8,11,12,18,19 the physio-
logical response of some of these bowel conduits during
ischemic events is different. The lack of serosa in the poster-
ior aspect of the ileum and colon compared with an intact
serosal layer throughout the circumference of the jejunum is
a possible hypothesis for the difference in behavior of these
conduits during a period of ischemic/reperfusion injury.
However, up to this point and to our knowledge, no prior
study has demonstrated this difference. Using a murine
model of ischemia/reperfusion injury, we compared the
same segment of bowel with and without serosa to prove
our theory.
This technique could be extrapolated to humans; how-
ever, there could be several challenges and limitations such
as an increased operating time since the bowel conduit
required for a normal esophageal reconstruction will be
longer, and this technique has also a surgical learning curve.
In addition, the patient will be exposed to the potential risks
of this technique such as full thickness injuries, possible
bowel leaks, necrosis, and compromise of the blood supply to
the conduit.
The main purpose of using this technique was to create a
murine model that mimics the normal lack of serosa in the
posterior wall of the terminal ileum and ascending colon and
compare this to the complete lining of serosa in the jejunum.
We believe that one alternative is to strip the serosa of the
mesentery, as this will avoid the potential complications
related to performing this technique over bowel andwill save
operating time.
However, and up to now, there are no other techniques or
alternatives that describe a complete deserosalization of the
bowel, as webelieve this technique is too risky to extrapolate
in humans.
Based on defined markers of ischemia, inflammation, and
angiogenesis, we were able to find some of the answers to
our question. The segment of bowel that lacked serosa was
able to survive and to showa lesser degree of ischemic injury.
On gross appearance, the color and motility were better as
compared with the conduit with an intact serosal layer. At
themolecular level, the increased number of CD34 cells with
a better histological pattern demonstrates a lesser degree of
ischemiawith a faster angiogenesis phase at its recipient site.
In addition, the decreased levels of LDH, IL-1β and IL-6
correlatewith a decreased level of inflammation and a better
adaptation/neovascularization process of the free bowel
conduit (►Fig. 9). Extrapolating these data into the clinical
setting, we can now presume why during an ischemic insult
some of these bowel conduits have a different physiological
behavior. Based on these results, we believe that the process
of angiogenesis and neovascularization of these bowel con-
duits is different during ischemic insults, making the bowel
flaps with less serosa a faster conduit to adapt and
neovascularize.
Conclusions
The use of free bowel conduits has been shown to be a safe
and effective treatment option. However, based on the
patient’s clinical background, appropriate selection of a
bowel conduit is imperative to minimize complications
during possible ischemic events.
Note
This paper was presented at the American Society of
Reconstructive Microsurgery, Waikoloa, HI, 2017.
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